NanoString Immunology Panel Grant
Does your research involve immunology based gene expression analysis?
If so, apply today for our nCounter Immunology Panel Grant! From now until Tuesday 19th April 2022, we are inviting researchers in Europe, the Middle East and Africa to submit your gene expression research abstracts (500-words only) for a chance to win 12 samples of the immunology panel of your choice. Should you know anyone interested, feel free to invite them to apply too!
This Grant closed on Tuesday 19th April, 2022
Save Time. Start Counting.
The nCounter® platform provides a simple and cost-effective solution for multiplex analysis of up to 800 RNA, DNA, or protein targets. Accelerate your research with just 15 minutes total hands-on time without amplification, cDNA conversion, or library prep, and generate publication-ready figures in ~24 hours.
Translational research and biomarker discovery has never been faster! NanoString has a broad portfolio of expertly curated, ready-to-use Gene Expression Panels. Each multiplex panel contains up to 770 genes and is customizable up to 30 additional unique targets. All nCounter gene expression panels are sold in increments of 12 reactions. SPRINT Reagents and Cartridges are also required and sold separately.
Learn more about the Immunology Panels and the nCounter® platform below:
View a short webinar: ‘Introducing the 15 min multi-plex gene expression system‘
View the webinar from previous panel grant winners: ‘The Winners Clube Series: nCounter Immune Exhaustion Panel‘
NanoString solutions have been used in more than 4,000 peer-reviewed publications. Check out our publications database!
*See terms and conditions below. All nCounter gene expression panels are sold in increments of 12 reactions. Reagents and Cartridges are also required and sold separately.
Terms and Conditions
Award Selection Criteria:
- Project feasibility in the 6 month period
- Gene expression multiplex between 200 to 800 genes
- Potential to publish the results on high impact factors (and number of articles) as determined by the judges
Grant submissions must be received by 11:59 PM Central European Time on Tuesday 19th April 2022.
Publication of Results:
All grant submissions are confidential to the individual submitter and will not be published or distributed. Upon project completion, the grant winner agrees to participate in one of the following activities relating to the specific project, with specific details of the applicable activity to be mutually agreed upon in good faith by NanoString and the winner: local seminar, webinar, case study, blog post, or poster presentation. Each winner agrees that NanoString shall have the right to use de-identified data from the winner’s project in application notes or marketing literature.
Eligibility and Requirements:
In order to be eligible to win the grant of the nCounter® gene expression panel, applicants must be located in either Europe, the Middle East or Africa and actively enrolled at an academic institution or employed at a research facility in a capacity in which they are able to perform research on and have capabilities to collect samples as well as run their project as described in the submitted abstract. The grant winner must be age 18 or older. Members of the immediate families of NanoString employees and directors, and persons living in the same household as such persons, are ineligible for this grant.
NanoString Technologies, Inc. is the sponsor of this gene expression panel grant program. No purchase is necessary to enter. By applying for the grant, each applicant agrees to these terms and conditions and that NanoString may process the personal data he or she provides in accordance with NanoString’s privacy policies available at nanostring.com/privacy. This grant program is void where prohibited or otherwise restricted by law. The grant winner or its applicable institution is responsible for any tax liability incurred by accepting the system loan. This is not a “cash in hand” grant and the grant winner has no option to receive any cash payment or alternative award in lieu of the gene expression panel. The grant may not be transferred or assigned. NanoString has not made any warranty, representation, or guarantee, express or implied, with respect to the grant, including, without limitation, the loaned system’s quality or fitness for a particular purpose. If, for any reason, the grant program cannot be run as planned for any causes beyond NanoString’s reasonable control, then NanoString reserves the right in its sole discretion to cancel, modify or suspend the grant program. These terms and conditions and any action related to this grant program are governed by the laws of the State of Delaware, USA, without regard to its conflict of law provisions.
For Research Use Only. Not for use in diagnostic procedures.